The presence of CAD or MI did not influence the effect of spironolactone in HOMAGE endpoints, namely systolic blood pressure, PICP, CITP, PIIINP, NT‐proBNP, LV mass, or left atrial volume. The gene discussed is NPPB; the disease is coronary artery disorder.